Gut-Heart Axis: Microbiome Involvement in Restrictive Cardiomyopathies
An intriguing aspect of restrictive cardiomyopathies (RCM) is the microbiome role in the natural history of the disease. These cardiomyopathies are often difficult to diagnose and so result in significant morbidity and mortality. The human microbiome, composed of billions of microorganisms, influenc...
Saved in:
Main Authors: | Samuel Jaimez-Alvarado, Itzel Ivonn López-Tenorio, Javier Barragán-De los Santos, Dannya Coral Bello-Vega, Francisco Javier Roldán Gómez, Amedeo Amedei, Enrique Alexander Berrios-Bárcenas, María Magdalena Aguirre-García |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/13/1/144 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fabry cardiomyopathy: Gb3‐induced auto‐reactive panmyocarditis requiring heart transplantation
by: Andrea Frustaci, et al.
Published: (2020-06-01) -
Fabry disease – what a gastroenterologist should know
by: Alicja Rydzewska-Rosołowska, et al.
Published: (2023-12-01) -
Clinical characteristics of female Fabry disease patients with hypertrophic cardiomyopathy with mid-ventricular obstruction
by: Natsuko Inagaki, et al.
Published: (2025-03-01) -
Clinical manifestations in Egyptian Pompe disease patients: Molecular variability and enzyme replacement therapy (ERT) outcomes
by: Mohamed Abdelghafar Hussein, et al.
Published: (2025-01-01) -
The efficacy and safety of itopride as an add-on
therapy to a proton pump inhibitor in the treatment
of gastroesophageal reflux disease
by: Dorota Wasko-Czopnik, et al.
Published: (2023-12-01)